Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice

F B Weihmuller1, M Hadjiconstantinou, J P Bruno

  • 1Department of Psychology, Ohio State University, College of Medicine, Columbus 43210.

Neuroscience Letters
|February 15, 1988
PubMed

Insights

MPTP-induced dopamine depletions in mice cause no obvious deficits normally. However, stress or haloperidol reveals significant sensorimotor impairments, validating this as a Parkinson

Area of Science:

  • Neuroscience
  • Animal Models
  • Parkinson's Disease Research

Background:

  • MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) causes striatal dopamine depletions.
  • These depletions are relevant to Parkinson's disease neurodegeneration.
  • Previous studies show MPTP-induced deficits are not always apparent.

Purpose of the Study:

  • To investigate the impact of MPTP-induced striatal dopamine depletions on sensorimotor behavior in mice.
  • To determine if behavioral deficits manifest under specific conditions.
  • To assess the utility of this model for Parkinson's disease research.

Main Methods:

  • Induction of striatal dopamine depletions using MPTP in a mouse model.
  • Assessment of sensorimotor behaviors under normal conditions.
  • Evaluation of behavioral responses following acute stress (cold swim) and pharmacological challenge (haloperidol).

Main Results:

  • MPTP administration did not produce obvious behavioral deficits in mice under normal conditions.
  • Acute stress or low-dose haloperidol injection induced significant akinesia, catalepsy, and sensory neglect.
  • These findings demonstrate that behavioral impairments are present but require specific triggers to manifest.

Conclusions:

  • Significant sensorimotor deficits accompany MPTP-induced neurotoxicity in mice.
  • The MPTP mouse model is valuable for studying Parkinson's disease mechanisms.
  • Behavioral assessment under stress or pharmacological challenge is crucial for uncovering subtle deficits.

Related Concept Videos